Menu

What Is a Mesothelioma Prognosis?

A mesothelioma prognosis is a doctor’s prediction of how the disease will progress. The rarity of mesothelioma significantly impacts our understanding of its prognosis, as the limited number of cases restricts the breadth of medical data available. This scarcity not only hinders research but also challenges the development of effective treatments. Mesothelioma is often diagnosed at an advanced stage, making early detection crucial for improving outcomes. The prognosis varies widely depending on factors such as the stage of cancer, the patient’s overall health, and the type of treatment received. Given the serious nature of mesothelioma, the disease can cause significant physical and emotional distress.

Seeking support from loved ones, healthcare professionals, and support groups can provide essential assistance. Remember, each case is unique, and there is always hope. If you suspect asbestos exposure or experience symptoms like shortness of breath, chest pain, or persistent cough, consult your doctor immediately, as early detection can greatly enhance your prognosis. It’s important to remember that a prognosis is not a definitive outcome but a tool to guide treatment decisions. While historical data can provide insights, every patient’s journey is unique. Open communication with your doctor is essential to understanding your prognosis and exploring available options.

Important Factors That Affect Mesothelioma Prognosis

Every mesothelioma case is unique, but several key factors influence a patient’s prognosis. Understanding these factors can help you and your doctor make informed decisions about your treatment plan.

This is an image of mesothelioma with a tumor.

Mesothelioma Types and Tumor Locations

The location of your tumor can significantly impact your prognosis. Mesothelioma is often found in the lining of the lungs, abdomen, heart, or, in rare cases, the testicles. Tumors in the abdomen generally have a better outlook than those in the lungs or heart. Heart mesothelioma, in particular, is rare and aggressive and often diagnosed posthumously.


This is an image of a cell.

Mesothelioma Tumor Cell Type

The type of cells in your tumor also affects prognosis. There are three main cell types: epithelioid, sarcomatoid, and biphasic (a combination of both). Epithelioid tumors respond better to treatment and have a median survival rate of 18-24 months. In contrast, sarcomatoid tumors are more aggressive, with a median survival rate of 4-6 months. Biphasic tumors vary, with survival rates depending on the dominant cell type, averaging 10-15 months. Epithelioid cells tend to respond better to treatment because they do not metastasize (grow and spread) as quickly as sarcomatoid cells.


This is an icon showing the 4 different stages of mesothelioma.

Early or Late Stage of the Disease

Early detection of mesothelioma significantly improves a patient’s prognosis. However, due to its long latency period and vague symptoms, it is often diagnosed in later stages when it has already begun to spread. Mesothelioma is staged from 1 to 4, with earlier stages responding better to traditional treatment options like surgery and chemotherapy. In later stages, especially when it spreads to the lymphatic system, treatment options become more palliative (focused on relief rather than cure).


This is an icon of chemotherapy.

Available Multimodal Treatment Options

Access to a combination of treatments such as surgery, chemotherapy, radiation, and immunotherapy can positively impact prognosis. Multimodal treatment options tend to improve outcomes. Additionally, some patients may qualify for clinical trials or experimental treatments that offer potential benefits. Consult your doctor for information on clinical trials that you may be eligible for. It’s essential to have open conversations with your doctor about your prognosis. They can explain how these factors impact your specific situation. While there’s no guaranteed outcome, knowledge empowers you to make informed decisions about your care.

Factors Affecting Mesothelioma Prognosis

Mesothelioma is a serious disease caused by exposure to asbestos, a harmful mineral once widely used in many products. Breathing in asbestos fibers can lead to mesothelioma. While asbestos is the primary cause, other factors can also increase the risk, including exposure to other minerals like erionite, radiation therapy in the chest area, certain genetic changes such as a BAP1 gene mutation, and possibly viral infections like simian virus 40 (SV40), although more research is needed. It’s crucial to understand that having one or more of these risk factors does not guarantee the development of mesothelioma, as many individuals with these risk factors never develop the disease.

While ongoing research explores additional potential links to mesothelioma, these factors are not yet proven causes. Some studies have suggested that living near industrial areas and certain dietary influences are possible risk factors, though more research is necessary to confirm these links. It’s important to note though that some factors do not affect the prognosis of mesothelioma. Smoking, unlike in other types of cancer, does not worsen the prognosis of mesothelioma. Similarly, while maintaining a healthy diet and regular exercise are beneficial for overall health, they do not directly impact the course of mesothelioma.

Patient Demographic Factors That Affect Survival Rate

Several demographic factors related to a patient’s background can influence their response to mesothelioma treatment. Younger patients often tolerate treatment better and generally have a more favorable outlook. Individuals in good overall health also tend to respond more positively to treatment. Women typically have a better prognosis than men for reasons that are not entirely understood. Although mesothelioma is more common in Caucasians, all races and people are susceptible to exposure. It is important to remember that these factors represent only part of the overall picture. Each patient’s situation is unique, and discussing your specific prognosis with your doctor is the best way to gain a comprehensive understanding.

Taking Control of Your Mesothelioma Prognosis

While many factors influencing prognosis are beyond your control, there are steps you can take to support your overall well-being. Remember, every patient’s journey is different, so it’s important to focus on what you can control and prioritize your physical and emotional well-being.

  • Maintain a healthy lifestyle: Eating a balanced diet, exercising regularly, and managing stress can help strengthen your body.
  • Seek support: Connect with other mesothelioma patients through support groups or online communities. Sharing experiences can provide emotional support and valuable information.
  • Stay informed: Learn about the latest treatment options and research advancements.
  • Second opinions: Consider seeking opinions from multiple specialists to explore all available treatment possibilities.

Mesothelioma Patient’s General Health

Your overall health plays a significant role in your prognosis. Healthier patients may be eligible for more impactful, curative treatment options. They will also likely have a stronger immune system, making them more receptive to treatment. Smoking should be avoided, as it can worsen the results and a healthy diet is always beneficial.

Overwhelmed by your mesothelioma diagnosis or treatment? Download our free guide to learn more about the disease.
Download Guide

There is no definitive answer for how long a person can live with this disease. A majority of patients diagnosed with mesothelioma live for less than one year. However, every case is unique and may have different behaviors and disease courses for different individuals. Physicians will evaluate your cancer cell type, perform laboratory assessments, and evaluate your individual demographics to determine your unique prognosis. Known poor prognostic factors include:

• N2 disease
• Nonepithelioid histology
• Poor performance status
• Chest pain
• Aged > 75 years
• Male gender
• White blood cell count ≥ 8.3 × 109/L
• Platelets > 400,000/mcL
• Lactose dehydrogenase (LDH) > 500 units/L
• High uptake on positron emission tomography (PET) scan

Mesothelioma survival statistics can be intimidating, but they don’t always show the full picture. They are not a precise prediction of your life expectancy; rather, they reflect past patients’ outcomes. Additionally, some of these outcomes may be based on data from statistics before the currently available advancements in diagnosis and treatment. General mesothelioma survival statistics often do not take into account specific factors like location (pleura, peritoneum, or pericardium), cell type, stage, or the overall health of individual patients.

Currently, researchers are working diligently to find better treatment options. Some offer patients in earlier stages curative help, and others can serve patients with advanced mesothelioma more palliative options to improve their overall quality of life. Because this disease is rare, it’s important to see a doctor who specializes in the treatment of this particular cancer type (called an oncologist). Together, you will be able to determine the best possible treatment options available tailored to your unique case.

Demographic Factors That Affect Survival Rate

Race

While mesothelioma is primarily found in Caucasians, studies have shown that African American and black patients diagnosed with the illness generally have a better prognosis. Of the cases reported, self-identifying black individuals tend to be younger females. However, survival rates are not necessarily higher, as black patients tended to not undergo surgery as often as white patients. Because this cancer is so rare in non-whites, accurate survival rates are not currently available.

Biological Sex

Women tend to have more favorable results than men. The Society of Thoracic Surgeons released a study showing that male patients had a survival rate of 4.5 percent compared to females, who had a survival rate of 13.4 percent. Researchers are unsure of why this is the case, but they believe hormones may be a factor. Research shows it could also be that women are more likely than men to see a doctor as soon as symptoms appear.

Risk Factors That Can Worsen Prognosis

Certain factors are associated with poorer outcomes for mesothelioma patients. Understanding these factors helps patients and doctors make informed decisions about treatment and care. While these factors can influence prognosis, they don’t determine a specific outcome. Medical advancements and individual responses to treatment vary widely:

  • Advanced stage: Cancer that has spread to distant organs or lymph nodes.
  • Aggressive tumor type: Sarcomatoid or biphasic mesotheliomas tend to be more aggressive.
  • Poor overall health: Underlying medical conditions can impact treatment tolerance.
  • Specific lab results: Elevated levels of certain markers, like LDH or white blood cells, can indicate more advanced disease.
  • Imaging findings: Evidence of widespread cancer on scans like PET or CT.

Understanding these factors helps patients and doctors make informed decisions about treatment and care. While these factors can influence prognosis, they don’t determine a specific outcome. Medical advancements and individual responses to treatment vary widely.

How to Improve a Mesothelioma Prognosis

The type of mesothelioma and stage of diagnosis greatly determine the treatment options available to patients. In early stages, while tumors are still localized within the body, doctors are often able to use a multimodal treatment approach to eradicate the cancer completely. Surgery is often coupled with chemotherapy or radiation for a treatment plan.

Unfortunately, if mesothelioma spreads, treatment options become less available, and the prognosis worsens. Most mesothelioma patients are diagnosed at stage 3, often ruling out the possibility of resecting the entire tumor through surgery. By the time it reaches stage 4, tumors have spread throughout the body and likely reached the lymphatic system. Traditional treatment options may still be used, but they are generally used as palliative care to relieve patient pain and improve comfort. However, every case is different, and there are ways to improve your mesothelioma prognosis.  Understanding your prognosis is crucial for making informed decisions about your healthcare. While mesothelioma can be a challenging diagnosis, it’s essential to remember that treatments are continually improving. To learn more about your options and get personalized support, connect with a mesothelioma patient advocate.

Mesothelioma Support Team

Mesothelioma Hub is dedicated to helping you find information, support, and advice. Reach out any time!